Fig. 4From: Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironmentTargeting FGF/FGFR signaling to regulate the cancer-immunity cycle in multiple stepsBack to article page